Editorial: Time for a New Conversation on Stimulant Use

Psychostimulants are one of the safest and most efficacious pharmacological interventions for a psychiatric disorder. In 1999 the groundbreaking Multimodal Treatment of ADHD (MTA) study set the standard of care for long-term treatment for children with attention-deficit/hyperactivity disorder (ADHD).1 Since then, stimulant use has increased substantially around the world.2 Because ADHD is a chronic condition, guidelines recommend re-evaluating the continued use of stimulant medications over many years in order to assess symptom relief and associated poor academic, social and work-life functioning.

Source: Journal of the American Academy of Child and Adolescent Psychiatry - October 17, 2019 Category: Psychiatry Authors: Alice Charach Tags: Editorial Source Type: research